Motilal Oswal's research report on Pidilite Industries
Sales in 4QFY22 were in line. Its revenue performance was commendable, given the COVID-led disruptions in Jan’22 and a high base of 44.7% in 4QFY21. Two/three-year CAGR was also healthy at 27.5%/15.2%. Higher than expected raw material prices eroded gross margin, resulting in a significant miss on EBITDA in 4QFY22. While some price hikes were taken in May’22, the management expects VAM prices to remain elevated over the next three-to-four months before softening in 2HFY23.
Outlook
The rich multiple of 57x FY24E EPS adequately captures the stock’s fair value. We maintain our Neutral rating.
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.